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942Objective: Previously, we showed that antegrade stent grafting of the descending thoracic aorta during DeBakey
type I dissection repair improves distal aortic remodeling. We assessed midterm outcomes of this reconstructive
strategy compared with standard open repair.
Methods:DeBakey type I dissections (non-Marfan, nontotal arch cases only) from 2005 to 2012 were retrospec-
tively reviewed. One hundred eighty patients underwent standard open repair (standard group), and 62 patients
underwent open repair plus stenting (stented group). Open repair entailed ascending aorta plus transverse hemi-
arch reconstruction under circulatory arrest, with variable aortic root work. Data was prospectively maintained.
Results: Preoperative parameters were similar. Patients in the stented group had longer circulatory arrest time
and higher utility of antegrade cerebral perfusion (P< .001). In-hospital/30-day mortality (10% vs 14%;
P ¼ .51), stroke (5% vs 8%; P ¼ .6), and paraplegia (0% vs 1%; P ¼ 1) were similar in the stented versus
standard groups. Mean follow-up was 2.7 2.3 and 2.2 2.1 years. Actuarial survival in stented versus standard
groups at 1 and 7 years was 86% versus 81% and 76% versus 60% (P ¼ .5). Thoracic aorta false lumen oblit-
eration was improved in the stented group (82% vs 39%; P<.001), along with improved freedom from open
distal aortic reoperation rate (98% vs 90% at 6 years, P¼ .1). Endovascular distal aortic reintervention rate was
higher in the stented group (18% vs 3%; P ¼ .008), with zero mortality.
Conclusions: Antegrade stent graft deployment during acute DeBakey type I dissection repair is safe method to
promote distal aortic remodeling without increasing postoperative or midterm mortality. This technique
provides increased freedom from open distal aortic reoperations compared with standard open repair. (J Thorac
Cardiovasc Surg 2014;147:942-50)Even with current advances in surgical technique, circula-
tory management, and postoperative care, acute type A
aortic dissection is associated with significant morbidity
and mortality.1-10 Open surgical repair focuses on
primarily on proximal aortic reconstruction with
stabilization of the aortic arch. As an institutional
practice, we perform ascending aorta replacement with
transverse hemiarch reconstruction under circulatory
arrest for type A aortic dissection, unless the tear site
involves the aortic root or arch. The majority of patients
present with DeBakey type I acute dissection, where the
flap extends into the descending aorta ending at the aortice Division of Cardiovascular Surgery,a University of Pennsylvania, Philadel-
Pa; and the Mayo Clinic,b Rochester, Minn.
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The Journal of Thoracic and Cardiovascular Surgbifurcation. Standard current surgical practice does not
address the dissection component involving the
descending aorta. Several studies show that the remnant
distal aortic pathology is associated with significant
morbidity and mortality over long-term follow-up. In pa-
tients requiring open distal aortic reoperation, the mortality
can be as high as 30%.11-13
The advent of thoracic endovascular aneurysm repair
(TEVAR) technology for proximal descending thoracic
aorta (DTA) pathology opened the door for its potential
utility in the repair of aortic dissection.14-19 In DeBakey
type I dissection, patients presenting with malperfusion
syndromes, where the associated mortality is significantly
higher, we started performing concomitant TEVAR of
the DTA to stabilize and improve true lumen flow in
the remnant dissected aorta. We reported our initial
experience and short-term outcomes of concomitant ante-
grade stent grafting of DTA during open dissection
repair.7,20 It showed that this technology could be applied
without increasing postoperative and short-term morbidity
and mortality. In a concurrent series, we compared DeBa-
key type I acute aortic dissection patients who underwent
standard open repair versus open repair plus antegradeery c March 2014
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
DTA ¼ Descending thoracic aorta
CT ¼ computed tomography
RCP ¼ retrograde cerebral perfusion
TAAA ¼ thoracoabdominal aortic aneurysm repair
TEVAR ¼ thoracic endovascular aneurysm repair
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From June 2005 to June 2012, 398 patients (Marfan syndrome and total
arch patients excluded) presented with ascending aortic dissection, of
whom 242 presented with acute DeBakey type I aortic dissection. Diag-
nosis was confirmed by computed tomography (CT) scan and intraopera-
tive transesophageal echocardiography before initiating surgery. The
decision for standard open repair versus open repair plus antegrade stent
grafting was surgeon preference. Stent grafting was adopted by 2 surgeons,
whereas 3 others performed standard repair only. All patients were accrued
in a contemporaneous fashion. Sixty-two patients underwent concomitant
DTA stent grafting (stented group) and 180 had standard open repair (stan-
dard group). All patients had open distal transverse hemiarch anastomosis.
All patients gave informed consent. Patients were followed prospectively.
All patients received postoperative CT scan at discharge or at 1 month
follow-up, and then every 6 months for the first 2 years, and then yearly
thereafter. Institutional Review Board approval was obtained for this study.
Statistical analysis was performed using SPSS version 15.0 (IBM-SPSS
Inc, Armonk, NY), and the Student t test was used to assess differences be-
tween the groups for numerical parameters. The Fisher exact test was used
for categorical parameters.
Operative Technique
All patients were emergently brought straight to the operating room,
where the diagnosis was confirmed by CT imaging or echocardiography.
Upon confirmation and obtaining informed consent, invasive monitoring
was established using arterial line and pulmonary artery catheter. Upon in-
duction, transesophageal echocardiography was performed to confirm the
diagnosis and establish the operative strategy. When CTwas not available
to measure the proximal dissected DTA, echocardiography was used to
obtain the diameter of the distal arch and the mid-DTA. Cardiopulmonary
bypass constituted venous drainage via right atrial cannulation along with
selective superior vena cava cannulation in patients elected for retrograde
cerebral perfusion during circulatory arrest. Arterial cannulation for
stented versus nonstented groups, respectively, was as follows: femoral ar-
tery (n¼ 19, n¼ 26), axillary artery (n¼ 16, n¼ 44), and direct true lumen
cannulation of ascending aorta/arch (n¼ 27, n¼ 110). In all cases, cerebral
oximetry was used, and intraoperative carotid artery flowwas confirmed by
2-dimensional Doppler. In addition, continuous electroencephalogram was
used when available. Left ventricular vent was placed in all cases. During
systemic cooling proximal aortic work was performed as previously
described. The extent of aortic root work was determined by the proximal
root and valve anatomy. Systemic cooling was performed to encephalo-
gram flat line or for 50 minutes.
Circulatory arrest was initiated with either antegrade cerebral perfusion
(ACP) or retrograde cerebral perfusion (RCP). ACP was established via
axillary artery with proximal snare, or via direct ostial cannulation of the
great vessels. For RCP, the superior vena cava was snared and cerebralThe Journal of Thoracic and Caflow was established at jugular venous pressure of 25 to 30 mm Hg. The
remnant ascending aorta and majority of the lesser curve of the arch was
resected. The dissection flap was then repaired with Teflon felt neomedia
(DuPont, Wilmington, Del) to obliterate the false lumen in the proximal
DTA and arch. In standard group patients, an appropriately sized Dacron
graft (Vascutec Ltd, Renfrewshire, Scotland) was sewn to complete the
transverse hemiarch reconstruction.
In the stented group, after creation of the Teflon felt neomedia, a 150-
mm length GoreTAG aortic stent graft (WL Gore & Associates, Flagstaff,
Ariz) was chosen at 15% larger than the measured proximal DTA diameter.
The stent graft was deployed into the true lumen of the DTA under direct
vision, with the proximal scallops of the GoreTAG abutting the origin of
the left subclavian artery by the greater curve, and at the edge of repaired
aorta along the lesser curve. The stent graft was then gently balloon dilated
to attain proper apposition against the aortic wall. The stent graft was then
secured proximally with 2 to 3 interrupted sutures, and then the Dacron
graft transverse hemiarch anastomosis was performed in standard fashion.
Along the lesser curve, whenever possible, the stent graft was incorporated
into the Dacron graft suture line. The conduct of the rest of the operation
was performed as previously described.20RESULTS
Preoperative Parameters and Operative Outcomes
Preoperative risk factors were similar in the 2 groups,
with 10% of patients requiring reoperative cardiac sur-
gery at the time of presentation with DeBakey type I dissec-
tion (Table 1). Two out of 3 patients were men, and
hypertension was the most common comorbidity in both
groups. Stented group patients had higher rates of malperfu-
sion syndrome at presentation (48% vs 39%), although this
was not significant (P ¼ .23) (Table 2). Cardiopulmonary
bypass (232  37 vs 218  59 minutes; P ¼ .07), aortic
crossclamp (171  40 vs 143  50 minutes; P ¼ .001),
and total circulatory arrest (55  18 vs 37  18 minutes)
times were longer in the stented group compared with the
standard group. Aortic root replacement and aortic valve
replacement rates were similar in both groups (P was
nonsignificant). ACP strategy during circulatory arrest
was employed more commonly in the stented group (69%
vs 24%; P<.001), given the expected longer circulatory ar-
rest time for antegrade stenting.
Overall, postoperative outcomeswere similar (Table 2). In-
hospital/30-day mortality was similar between the stented
and standard groups (10% vs 14%; P ¼ .51). The majority
of this mortality in the stented group (n¼ 5) occurred during
the first 15 months of adopting the antegrade TEVAR tech-
nique as part of the DeBakey type I dissection repair. Since
then there has been 1 death in the stented group,whereasmor-
tality in the standard group has remained the same throughout
follow-up. There were no differences in stroke (5% vs 8%;
P¼ .57), renal failure (21% vs 23%;P¼ .45), or reoperation
for bleeding (11% vs 8%; P ¼ .45) rates. One patient expe-
rienced permanent paraplegia in the standard group (none in
the stented group). Transient spinal cord ischemia rate was
higher in the stented group (6% vs 2%), although this was
not significant (P ¼ .08). Hospital length of stay was similar
(16  12 vs 14  12 days; P ¼ .4).rdiovascular Surgery c Volume 147, Number 3 943
TABLE 1. Preoperative characteristics by patient group
Stented (n ¼ 62) Standard (n ¼ 180) P
Age, y 58.2  11.9 59.4  13.9 .8
Male,% 40 (65) 125 (69) .52
Prior sternotomy 6 (10) 19 (11) .8
Prior AAA repair
(open or EVAR)
1 (2) 7 (4) .7
Hypertension 51 (82) 147 (82) 1
Renal failure 3 (5) 17 (9) .42
Diabetes 8 (13) 21 (12) .82
Chronic lung disease 6 (10) 18 (10) 1
Malperfusion 30 (48) 70 (39) .23
Data are presented as mean  standard deviation or n (%). AAA, Abdominal aortic
aneurysm; EVAR, endovascular aneurysm repair.
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DAortic Remodeling and Aortic Reinterventions
Fifty-five patients (98%) in the stented group had CT
follow-up, comparedwith 120 patients (77%) in the standard
group. CT images were evaluated for complete or thoracic
false lumen obliteration versus thoracic residual false lumen
patency with or without abdominal segment. Antegrade
DTA stenting promoted false lumen obliteration in the
thoracic aorta compared with the standard group (P<.001).
Complete or thoracic false lumen obliteration rate was 82%
(n¼ 45) in the stented group versus 39% (n¼ 47) in the stan-
dard group (Table 3). Even though complete false lumen
obliteration rates were similar (27% vs 23%), thoracic false
lumen obliteration rates were significantly improved in the
stented group (55% vs 16%; P<.0001).
Distal aortic reintervention rates were evaluated in both
groups with patients with any postoperative clinicalTABLE 2. Intraoperative and postoperative outcomes by patient group
Outcome Stented (n
Intraoperative
Root replacement 10 (16
Root reimplantation 0 (0)
Aortic valve replacement 8 (13
Cardiopulmonary bypass time, min 232 
Aortic crossclamp time, min 171 
Retrograde plus antegrade cerebral perfusion 8 (13
Retrograde perfusion 11 (18
Antegrade perfusion 43 (69
Circulatory arrest time, min 55  1
Postoperative
In-hospital/30-d mortality 6 (10
Stroke 3 (5)
Permanent paraplegia 0 (0)
Transient spinal cord ischemia 4 (6)
Ischemic bowel 3 (5)
Prolonged ventilation (>24 h) 14 (23
Renal insufficiency/failure 13 (21
With hemodialysis 4 (6)
Reoperation for bleeding 7 (11
Length of Stay, d 16  1
Data are presented as mean  standard deviation or n (%).
944 The Journal of Thoracic and Cardiovascular Surgfollow-up (Figure 1). In the stented group, 11 patients un-
derwent 11 single distal aortic reinterventions: 10 single
TEVAR procedures, and 1 redo total arch procedure in a pa-
tient with type IA endoleak. This was during our early expe-
rience with the antegrade TEVAR technique (ie, within the
first year). The overall open aortic distal reintervention rate
was 1.8% (n¼ 1), and TEVAR-only reintervention rate was
18% (n ¼ 10) in the stented group. There were zero multi-
ple distal reinterventions in the stented group. In the stan-
dard group, 12 patients underwent 16 distal aortic
reinterventions: 5 TEVAR procedures (2 patients with sin-
gle TEVAR only), and 11 open distal aortic reinterventions
(3 redo total arch procedures and 8 thoracoabdominal aortic
aneurysm repair [TAAA] procedures). Three patients in the
standard group had multiple distal aortic reinterventions, of
which 1 patient had extent I TAAA repair, followed by
extent III TAAA repair, followed by redo total arch repair
(Figure 1).
The overall open distal reintervention rate was 9.2%
(n ¼ 11) in the standard group, compared with 1.8%
(n¼ 1) in the stented group (P¼ .1). The overall open thor-
acoabdominal aortic repair rate was 7% (n ¼ 8) versus 0%
in the standard versus stented groups (P ¼ .06). In contrast,
TEVAR reintervention rates were significantly higher in the
stented group (18% [n ¼ 10] vs 4% [n ¼ 5]; P ¼ .006).
Perioperative mortality from all distal aortic reinterventions
was 0% in the stented group, and 9% in the standard group
(P¼ 1.0). Therefore, intraoperative antegrade TEVAR dur-
ing acute DeBakey type I dissection repair improved
thoracic false lumen obliteration rates on CT imaging¼ 62) Standard (n ¼ 180) P
) 36 (20) .57
3 (2) .57
) 37 (21) .22
37 218  59 .07
40 143  50 .001
) 19 (11) .64
) 117 (65) <.001
) 44 (24) <.001
8 37  18 .001





) 69 (38) .02
) 42 (23) .86
21 (12) .33
) 15 (8) .45
2 14  12 .35
ery c March 2014
TABLE 3. Status of the descending thoracic aorta false lumen status











Stented (n ¼ 55) 15 (27) 30 (55) 10 (18)
Standard (n ¼ 120) 28 (23) 19 (16) 73 (61)
Data are presented as n (%). *Full plus partial obliteration ¼ 82% in the stented
group, 39% in the standard group (P<.001).
Vallabhajosyula et al Acquired Cardiovascular Diseasefollow-up, and provided an endovascular platform in the
thoracic aorta that promoted increased utility of TEVAR
only as a distal aortic reintervention. Likely, the combina-
tion of improved thoracic false lumen obliteration, along
with the increased utility of TEVAR for thoracic aortic re-
intervention in the stented group also led to a decreased
requirement for open TAAA repair as a distal aortic reinter-
vention in the stented group compared with the standard
group (0% vs 7%; P ¼ .06).FIGURE 2. Kaplan-Meier survival curves for the stented versus standard





Mean follow-up was 2.7  2.3 years and 2.2  2.1 years
in the stented and standard groups, respectively. Actuarial
freedom from open distal aortic reintervention at 5 years
was 98% versus 90% in the stented versus standard groups,
respectively (log rank P¼ .1) (Figure 2, A). Cumulative sur-
vival in the stented versus standard groups at 1, 4, and 7
years was 86% versus 81%, 78% versus 78%, and 76%
versus 62% (log rank P ¼ .5) (Figure 2, B). Therefore, an-
tegrade TEVAR of the DTA during DeBakey type I dissec-
tion repair showed a trend toward improved open distalFIGURE 1. Stented versus standard groups: A, Distal aortic reinterven-
tions. B, Distribution of open and endovascular aortic reintervention cases.
TEVAR, Thoracic endovascular aneurysm repair.
The Journal of Thoracic and Caaortic intervention rate, without increasing early midterm
mortality.DISCUSSION
The novel concept of concomitant antegrade TEVAR
stenting of the proximal DTA during acute DeBakey type
I dissection repair at our institution emerged from integra-
tion of 2 main factors: patients with type A dissection
with severe malperfusion syndrome had higher mortality,
partly because the standard repair did not completely
address true lumen compression in the DTA, and develop-
ment of an endovascular platform for treatment of symp-
tomatic type B aortic dissection allowed extension of this
technology for treatment of DeBakey type I dissection. Pre-
viously, we reported the use of concomitant antegrade
TEVAR technique, with equivalent postoperative outcomes,
and improved thoracic aortic false lumen obliteration.20
Here, we report our midterm outcomes in a concurrent
series comparing standard open repair with open repair
plus TEVAR. Overall, our findings suggest that concomitant
TEVAR during type A dissection repair improves morbidity
associated with open distal aortic intervention rate.
Concomitant antegrade TEVAR during DeBakey type I
dissection repair can be safely employed, without
increasing postoperative morbidity and mortality.21-28rdiovascular Surgery c Volume 147, Number 3 945
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aortic crossclamp and circulatory arrest times were
significantly longer in the stented group. As routine
practice at our institution, transverse hemiarch
reconstruction under circulatory arrest is performed using
RCP under deep hypothermia. ACP via axillary
cannulation or direct ostial innominate artery and left
carotid artery cannulation is typically used for cases of
longer circulatory arrest. Although over the past 3 years
use of ACP for standard type A dissection repair is
increasingly used at our institution. Therefore, there is
discrepancy in the cerebral perfusion strategy in the
stented versus standard groups (Table 2). The slightly lower
stroke rate seen in the stented group (5% vs 8%) may be a
reflection of the increased use of ACP in the stented group
compared with the standard group, although this did not
reach statistical significance (P ¼ .6). Also, within the
stented group, there were no differences in neurologic out-
comes in patients where RCP alone was used compared
with ACP alone. Similarly, we did not observe increased
permanent paraplegia in the stented group, further attesting
to the safety profile of the concomitant antegrade TEVAR
technique. Given these findings, our study suggests that
manipulation of the aortic arch and DTA during antegrade
TEVAR can be safely performed, without increasing post-
operative or delayed stroke or paraplegia rates.
Even though antegrade TEVAR was initially used for
DTA-related malperfusion, the technique was extended
for treatment of aortic arch tears as well and is now more
routinely performed based on surgeon preference. Instead
of performing a total arch replacement, which can be asso-
ciated with higher stroke rate and longer circulatory arrest
time, coverage of the aortic arch tear can be safely achieved
using the antegrade TEVAR technique. With this ‘‘modified
frozen elephant trunk’’ approach the proximal end of the
stent graft is deployed right at the left subclavian artery
take-off along the greater curvature of the aortic arch, and
proximally along the lesser curve, the stent graft is inte-
grated into the transverse hemiarch graft suture line. In
the Stented group, 19 patients (31%) had aortic arch tears
that were treated using this modified frozen elephant trunk
technique, suggesting that to some extent there was a selec-
tion bias in the adoption of this technique for the treatment
of DeBakey type I acute aortic dissections with arch tears.
There has been 1 patient with an aortic arch complication,
where a type IA endoleak occurred secondary to undersiz-
ing the stent graft, requiring a delayed open redo total
arch operation due to arch dilation. This was the single de-
layed open distal aortic operation in the stented group. Pre-
operative CT imaging was not available in that particular
case, and stent graft sizing was determined by intraopera-
tive transesophageal dimensions. Since then, we have
stopped antegrade TEVAR in cases where preoperative
CT imaging is not available, and we perform standard total946 The Journal of Thoracic and Cardiovascular Surgarch replacement under ACP circulatory arrest. In the stan-
dard group, patients undergoing total arch replacement
were excluded from this study because these patients
constitute a population with even greater morbidity and
technical complexity and were deemed not an appropriate
control group for comparison. Overall, we believe that
this technique of modified frozen elephant trunk can be
safely employed for the treatment of DeBakey type I dissec-
tion with aortic arch tear instead of a total arch replacement.
We have not used this technique in patients with aortopa-
thies such as Marfan syndrome.
False lumen obliteration in the DTA was significantly
improved in the Stented group (82% vs 39%), even though
complete false lumen obliteration was similar in both
groups (27% vs 23%). This attests to the fact that even
though true lumen in the proximal DTA is stabilized and
expanded secondary to antegrade TEVAR, fenestrations in
the distal thoracic/abdominal aorta prevent complete false
lumen obliteration. Even though false lumen thrombosis
is improved with TEVAR, the aortic wall is still pressurized
in cases where complete obliteration is not present, and thus
it would still be prone to aneurysmal dilation. Therefore, we
have maintained close follow-up of the thoracic and abdom-
inal aorta with serial imaging in stented group patients.
Future studies looking into the aortic dilation rates in
stented versus standard group patients would help ascertain
if the improved DTA false lumen thrombosis in the stented
group translates into decreased need for frequent CT imag-
ing follow-up.
Overall late distal aortic reintervention rates were higher
in the stented group (20% vs 10%), although majority of
the reinterventions were single TEVAR cases. There was
1 open distal aortic reintervention in the stented group, as
mentioned above. Of the 10 TEVAR interventions, 8 were
performed during the first 2 years of adopting the antegrade
TEVAR technique. Since then, over the past 36 stented
cases, 2 single TEVAR distal aortic interventions were
required. Reasons for this likely include that there is clearly
a learning curve associated with adopting this technique. In
addition, initially, use of RCP with deep hypothermia dur-
ing circulatory arrest was used during antegrade TEVAR,
which may have affected the nitinol frame expansion under
cooler conditions, and thus led to a higher incidence of
distal landing zone endoleak. Preferentially, ACP circula-
tory arrest is used during antegrade TEVAR cases now,
which is performed under more moderate hypothermia con-
ditions. This may enable a better seal at the landing zones
due to better expansion of the nitinol skeleton of the endog-
raft. Also, at the beginning of our trial 100-mm length stent
grafts were used, compared with the 150-mm length stent
grafts that we use now. The added coverage in the latter
cases may have promoted greater DTA false lumen throm-
bosis and thus provided better distal seal. Even though TE-
VAR late distal aortic intervention was significantly higherery c March 2014
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mortality and no patients required second distal aortic rein-
tervention. Three patients in the standard group required
multiple distal aortic reinterventions, with 1 postoperative
death.
The most important difference over follow-up between
the 2 groups was the open distal aortic operation rates. Of
the 16 distal aortic reinterventions in the standard group,
11 were open operations (7.1% open distal reoperation
rate); compared with 1 out of 11 in the stented group
(1.7% open distal reoperation rate). So far, no patients
have required extent I, II, or III TAAA repair in the stented
group, compared with 7 in the standard group (P ¼ .1).
Eight patients (7%) in the standard group underwent at least
a second circulatory arrest period during their lifetime,
compared with 1 (1.8%) in the stented group. The ante-
grade TEVAR platform at the index operation thus
decreased the chance of DeBakey type I dissection patients
having to undergo a second episode of circulatory arrest
during their lifetime. Therefore, antegrade TEVAR during
DeBakey type I dissection repair improved morbidity over
midterm follow-up. This finding, in conjunction with the
follow-up CT imaging studies, supports the idea that
remnant distal aortic dilation occurs more rapidly with stan-
dard type A dissection repair than with open repair plus an-
tegrade TEVAR. Most likely this is due to the improved
false lumen thrombosis achieved in the stented group.
One would expect higher pressurization of the aortic wall
with a patent false lumen compared with a thrombosed false
lumen. Larger sample size and longer follow-up will be
required before we can further validate this idea clinically.
Interestingly, reducing open distal aortic interventions did
not improve survival over midterm follow-up in the stented
group. Longer follow-up with a larger sample size is
required to see if the potential benefit of improved thoracic
false lumen obliteration achieved with antegrade TEVAR
will translate into a survival benefit.
Further, when we compared the mean hospital length of
stay in patients undergoing distal aortic reintervention (ie,
TEVAR and open cases), the standard group patients had
significantly longer length of stay due to the higher open
distal aortic operation rate (P ¼ .002). In the stented group,
median hospital stay was 5 days, with mean of 11  14
days. In the standard group, median stay was 18 days,
with mean of 19  8 days. Therefore, from a cost analysis
standpoint, the cost of TEVAR stent graft at the index oper-
ation in the stented group is most likely offset by decreasing
the cost associated with open distal aortic reoperation,
which is associated with longer operative times and
increased hospital length of stay.
One of the weaknesses of this study is the incomplete
follow-up in the standard group (77%) compared with the
stented group (98%). Although we are unaware of any other
reports concurrently comparing midterm outcomes inThe Journal of Thoracic and CaDeBakey type I dissection repair techniques of stenting
versus nonstenting. Although this is a single institution
experience, individual surgeon preference played an impor-
tant role in determining which patient received antegrade
TEVAR versus not during DeBakey type I dissection repair,
and the circulatory arrest management strategy also varied
by surgeon preference. Therefore, this point has to be taken
into consideration. With further follow-up, if there is
consistent improvement in morbidity associated with open
repair þ antegrade TEVAR, and this translates to improved
mortality, then likely a randomized trial comparing the 2
DeBakey type I dissection repair platforms is warranted.
The authors thank Patrick Moeller and Rohan Menon for
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Dr G. Chad Hughes (Durham, NC). I would like to thank the
Association for the opportunity to discuss this work and congratu-
late Joe on a great presentation. Joe and Alberto, great work. I just
have a few questions.
Although the authors state their initial experience has led them
to use this technique more widely, it was used in only 26% of the
242 patients undergoing Debakey type I dissection repair during
this time interval. This indicates the presence of bias with regard
to patient selection, surgeon preference, or both. Please describe
in more detail how patients are selected to undergo this procedure
because it would appear that the vast majority still do not receive
this adjunctive antegrade stent graft repair.
Dr Bavaria. That is a very fair question. That gets into the
methods of selection a little bit, and there was a little bit of an evo-
lution—especially in the really early phases.
The first 6 we did were actually done for significant malperfu-
sion problems, and when we looked at them—this was presented at
the Annual Meeting of The American Association for Thoracic
Surgery in 2006—we saw that we had very good remodeling.
This was the impetus for the entire effort. The fact of the matter948 The Journal of Thoracic and Cardiovascular Surgis, in our institution there are 5 aortic surgeons who take dissection
call; 2 of them do the procedure and 3 of them do not. So that’s
the natural selection bias right there; the patients come in
randomly.
The other selection bias is that we do not do Marfan patients, so
the entire Marfan subgroup was excluded, and that’s about 15% of
cases. We do not perform the procedure in patients we believe will
have<10-year life expectancy from their age.
An analysis probably should be done to take out that side. But
that is the actual selection algorithm right there.
Dr Hughes. Yes. I would say if there is institutional buy-in, I
would question why 3 of the surgeons don’t do it.
Dr Bavaria. That’s a good question. I can’t answer that.
Dr Hughes. Okay. We’ll move on.
Dr Bavaria. I think they’re a little younger and may not be as
self-secure.
Dr Hughes. Yeah, got it.
Although the postoperative outcomes as presented suggest no
adverse effects of the addition of antegrade stent graft deployment
to standard dissection repair, the results are unadjusted and do not
take into account potential differences in the risk profiles of the
groups.
For example, the incidence of preoperative renal failure was
nearly double in the standard versus stented group, and the inci-
dence of preoperative shock or performance of concomitant coro-
nary artery bypass grafting was not reported, all of which are
predictors of composite mortality or major morbidity following
proximal aortic replacement based on data from more than
45,000 patients in the Society of Thoracic Surgeons database,
which we recently published in Journal of The American College
of Cardiology.
Further, the International Registry of Acute Aortic Dissection
has previously published a risk model for type A dissection repair
that could be used to risk adjust the patient cohorts, or ideally, the
analysis could be repeated with a propensity-matched design that
would better account for any potential differences between the
groups. Please comment on that.
Dr Bavaria.Wewent through the univariate analysis of the pre-
operative risk factors, and there wasn’t anything that was below
0.05.
But I totally agree with you. The next iteration should be a
propensity-matched analysis, and I totally agree that we should
do a little bit more robust analysis of preoperative factors to
make sure that we are comparing apples to apples here, and I think
a propensity analysis is perfect.
At some point we are probably going to have to do a prospective
randomized study on this. I think the equipoise is satisfactory
enough to do that. That probably will require a multicenter trial.
Dr Hughes. That gets to my last question: Although the
decreased need for open reintervention is interesting, it seemed
somewhat less compelling in the absence of the survival benefit.
Do you have any thoughts on why you’re not seeing a survival
benefit at this point?
Dr Bavaria. That is a very good question. I do not know why
there is not a survival benefit. You might think there should be.
Some of this may be because there was a significant learning curve
with the original 10 or 15 cases. We had to do some interventions
because we were placing the stents too distally, and as Eric Roselliery c March 2014
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imal—we figured that out.
We basically cover the subclavian artery. We bring it as far
proximal as possible. We don’t cut out the graft like Eric does,
but we do bring them as far proximal as possible.
That was probably something that affected the mortality rate on
the stented side at the beginning of the series. I do not really know
the answer. We’ll see.
Dr Hughes.Well, again, congratulations, and I echo your senti-
ment. I think this would bewell suited to a multicenter randomized
trial.
Dr Bavaria. Thank you very much, Chad.
Dr Marc R. Moon (St Louis, Mo). Joe, does this have to be a
covered stent graft? Couldn’t you just put in a stent? Wouldn’t it
effectively do the same thing?
Dr Bavaria. One of the reasons why it works in these selected
patients is because many times there is a large fenestration in the
proximal descending aorta that we cannot get to.
So if you have a large fenestration in the proximal descending
aorta, then a pure stent would maybe not work as well. It would
theoretically work as well if there were not a large communication
in the proximal descending aorta. But if you have a large commu-
nication in the proximal descending aorta, then you need a fully
covered stent.
DrAlberto Pochettino (Rochester, Minn). I just want to make a
couple of comments, because I was involved in this study.
The first issue raised regarding patient selection is a good one,
and I want to emphasize that this was awork in progress. The first 8
to 10 patients were indeed what I would call a pilot project; most
were patients who definitely had malperfusion and needed some-
thing more than a standard operation. We were impressed with
how good the results were in those initial, intrinsically high-risk
patients.
What came down within the University of Pennsylvania was
that 1 of the surgeons—myself—went on to generalize the use
of this technique to all Debakey type I dissections, with the only
exclusion being collagen vascular disease. The remaining sur-
geons were not compelled to embark on a modification that makes
an operation that is intrinsically difficult even more difficult and
increases the circulatory arrest time by about 20 minutes, without
clear-cut, up-front evidence that it would be of benefit.
Ultimately, as the results improved, some of the other surgeons,
Bavaria being one of them, started using the antegrade stent
technique.
As we think back, the issue remains as to whether or not this
technique is worthwhile. I don’t as yet know the answer. I’ve
been impressed that the technique is safe and reproducible, with
equivalent results to the standard type A repair.
As we analyze the long-term outcomes most of the patients in
the 2 groups, aside from the early pilot project, are indeed similar
in presentation and early outcomes. I don’t remember seeing a
particular bias regarding the stented group being sicker or not as
sick compared with the other groups. Again, the early pilot project
was a little bit different.
Dr Anthony Estrera (Houston, Tex). Joe, nice job. The concept
is good. I do like the concept, and if the data of the Investigation of
Stent Grafts in Patients With Type B Aortic Dissection trial bearsThe Journal of Thoracic and Caout as Nienaber has presented most recently at 5 years is anything
to go by, you should see a difference as your data matures.
My question is related to spinal cord ischemia and paraplegia.
Although it wasn’t significant, the P value was .07. Because the
stent-graft is thrombosing-remodeling—all those relevant inter-
costals—what are your thoughts about paraplegia and was your
study powered enough to show a difference?
Dr Bavaria.We probably do not have enough data right now. I
have a slide I didn’t show that is not just the survival differences
between the 2 groups as far as the learning curve is concerned,
but also the entire morbidity and mortality profile in the learning
curve.
We had 5 spinal cord ischemic events, and all 4 of those were in
the first part of the series. And that’s why at the beginning we
didn’t know how long the stents should be, and now we’ve kind
of standardized that. But you’re right, it is an issue.
Dr Eric E. Roselli (Celevand, Ohio). Joe, great presentation.
Just 2 really quick questions.
Despite the fact that you show there was more malperfusion and
longer circulatory arrest times in your stented patients, there was
really no difference in mortality. Did you do any additional adjunc-
tive procedures like stenting any static occlusions of organs down-
stream at the same time in any of your patients?
Dr Bavaria. No, we did not. The only adjunct is that we are do-
ing more and more of these operations in the endo suite now, so
when we put a stent in, we’ll shoot a completion angiogram.
Dr Roselli. Great. I think that’s an important part of the pro-
cedure. A serendipitous finding in my series was that I think we
can treat these patients with malperfusion better using the hybrid
suite.
My second question concern folks who had persistent false
lumen perfusion in the stented area on follow-up. Have you done
an imaging analysis to see if they had persistent dissection in the
branch vessels of their arches? I suspect that may be a common
area where a persistent entry tear was filling the false lumen of
the aorta.
Dr Bavaria. I agree with that concept. I think the differential
between my technique—or our technique—and maybe even
your technique and Di Bartolomeo’s technique right behind you,
is that they’re doing a total arch, and they have a sewn-in graft
where there is no communication. In other words, there is no land-
ing zone in this dissected aorta.
We’re getting into the mid-70s pretty consistently; between
70% and 80% success. But we have 20% to 25% nonsuccess
compared with what Roberto is going to tell us, probably 10%
with a full elephant trunk graft that is made for this.
So I think you’re right. There are either left subclavian or type
1A endoleak situations that you can think about. We had more of
these in the early phase because we learned a lot and put them up
more proximally now.
Dr Moon. Hopefully you’ve decreased the pressure so much in
that false lumen that it’s not going to be a problem and dilate over
time like it would be if you didn’t have the stent in there.
Dr Bavaria. I agree. I think that differential between putting a
stent in antegrade under a hemiarch condition compared with a to-
tal arch with a designed E-Vita type of graft (JOTEC, Hechingen,
Germany), that does explain the differential, which is about 15%.rdiovascular Surgery c Volume 147, Number 3 949
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angiogram? What can you do?
Dr Bavaria. As little as possible.
Dr Moon. Fifteen for 30?
Dr Bavaria. Yes.
Dr Roselli. Mine is 12.5 cc, 15 for 25 with half-strength
contrast.
Dr Bavaria. Ten for 30 or something like that. Right at the end
of the stent so it doesn’t get hung up.
Dr Roberto Di Bartolomeo (Bologna, Italy). Joe, my compli-
ments on your presentation and your technique. What do you think
about our initial experience in type B acute aortic dissection with
impending rupture and/or visceral malperfusion to use the frozen
elephant trunk technique?
Dr Bavaria. For type B?950 The Journal of Thoracic and Cardiovascular SurgDr Di Bartolomeo. Yes, for type B acute dissection when there
is impending rupture or/and distal malperfusion.
Dr Bavaria. With the E-Vita?
Dr Di Bartolomeo. Yes.
Dr Bavaria. Yes, it makes sense.
Dr Di Bartolomeo. Seventy percent of patients have the acute
aortic dissection in the ascending aorta, and 22% start in the de-
scending aorta. With our operation, the frozen elephant trunk, us-
ing the E-Vita—or now the Thoraflex, the new device from
Vascutek (Renfrewshire, Scotland)—it’s possible to remove the
ascending aorta and aortic tissue in the same operation, also
reducing the risk of the type A aortic dissection. Is it a good
idea?
Dr Bavaria. I think that is going to be the topic of our next
research project. That’s a nice segue.ery c March 2014
